CpG oligonucleotides are effective in immunotherapy of a minimal residual tumour disease after surgery or chemotherapy in a murine model of MHC class I deficient, HPV¨16-associated tumours

Reiniš, M., Šímová, J., Indrová, M., Bieblová, J., Jandlová, T., Bubeník, J. CpG oligonucleotides are effective in immunotherapy of a minimal residual tumour disease after surgery or chemotherapy in a murine model of MHC class I deficient, HPV¨16-associated tumours. In: Abstract Book. Praha: MSD, 2006, s. 336.